LeMaitre Q3 2024 Financial Results
LeMaitre Vascular, Inc. (LMAT)
Last lemaitre vascular, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
lemaitre.gcs-web.com/investor-relations
Company Research
Source: GlobeNewswire
BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance. Q3 2024 Financial Results Sales $54.8mm, +16% (+16% organic) vs. Q3 2023Gross margin 67.8%, +280 bpsOp. income $13.1mm, +43%Op. margin 24%Earnings per diluted share $0.49, +46%Cash up $10.8mm sequentially to $123.9mm Grafts (+24%), patches (+13%) and carotid shunts (+18%) drove Q3 sales growth. APAC sales increased 24%, EMEA 22% and the Americas 12%. The gross margin increased to 67.8% (vs. 65.0% in Q3 2023), driven by price increases and manufacturing efficiencies. Operating income of $13.1mm was up 43% vs. Q3 2023. Operating expenses grew 11.1% in Q3 largely due to additional sales offices and personnel. The company employed 28 sales managers and 146 sales reps at quarter end, up 17% and 7%, respectively. Chairman/CEO George LeMaitre said, “2024 is shap
Show less
Read more
Impact Snapshot
Event Time:
LMAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LMAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LMAT alerts
High impacting LeMaitre Vascular, Inc. news events
Weekly update
A roundup of the hottest topics
LMAT
News
- LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular declares $0.16 dividend [Seeking Alpha]Seeking Alpha
- LeMaitre to Participate at Upcoming Investor Conferences in NovemberGlobeNewswire
- LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.MarketBeat
LMAT
Earnings
- 10/31/24 - Beat
LMAT
Sec Filings
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- 11/15/24 - Form 144
- LMAT's page on the SEC website